226 related articles for article (PubMed ID: 19330826)
1. Anatomy of the patent foramen ovale for the interventionalist.
McKenzie JA; Edwards WD; Hagler DJ
Catheter Cardiovasc Interv; 2009 May; 73(6):821-6. PubMed ID: 19330826
[TBL] [Abstract][Full Text] [Related]
2. Package insert of shunt closure devices, for the doctor or for the lawyer?
Meier B
Catheter Cardiovasc Interv; 2009 May; 73(6):827. PubMed ID: 19367650
[No Abstract] [Full Text] [Related]
3. New onset atrial fibrillation after patent foramen ovale closure.
Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
[TBL] [Abstract][Full Text] [Related]
7. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
9. Early experience with a simplified technique for transcatheter closure of the patent foramen ovale.
Kutty S; Nykanen DG; Zahn EM
Heart Lung Circ; 2009 Dec; 18(6):384-7. PubMed ID: 19783211
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
14. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
15. Fracture of a GORE HELEX septal occluder following PFO closure in a diver.
Scott P; Wilson N; Veldtman G
Catheter Cardiovasc Interv; 2009 May; 73(6):828-31. PubMed ID: 19180658
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients.
Sievert H; Ruygrok P; Salkeld M; Baumgartner H; Meier B; Windecker S; Juliard JM; Aubry P; Tiefenbacher C; Krumsdorf U; Vermeersch P; Ewert P; Piéchaud JF
Catheter Cardiovasc Interv; 2009 Feb; 73(3):368-73. PubMed ID: 19133667
[TBL] [Abstract][Full Text] [Related]
17. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
18. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies.
Wöhrle J; Kochs M; Spiess J; Nusser T; Hombach V; Merkle N
Circulation; 2009 Jun; 119(23):3002-8. PubMed ID: 19487592
[TBL] [Abstract][Full Text] [Related]
19. Interatrial shunt closure devices in patients with nickel allergy.
Reddy BT; Patel JB; Powell DL; Michaels AD
Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
[TBL] [Abstract][Full Text] [Related]
20. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
